← Back to headlines
AstraZeneca and Bristol-Myers Squibb Merger Talks Impact Stocks, Puzzle Analysts
AstraZeneca shares slumped while Bristol-Myers Squibb jumped on reports of potential merger talks, which analysts found puzzling. The discussions could lead to the creation of the world's largest drugmaker, with multiple sources confirming the ongoing examination of a deal.
3 Aug, 09:04 — 3 Aug, 10:43
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (32/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left
Center1
Center (1)
marketwatch
Right1
Right (1)
irish-independent
Far R
Geographic diversity— 2 regions9/34
US1Ireland1
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
marketwatchMostly Factual1h ago
AstraZeneca tie-up talks with Bristol-Myers Squibb are moving stocks. Analysts are puzzled.
AstraZeneca shares were slumping while Bristol-Myers Squibb was jumping on Monday on reported deal talks. But the big question is why these two pharmaceutical giants would want to come together in the first place.
By Steve Goldstein
Read full article →irish-independent3h ago
AstraZeneca in talks over potential Bristol-Myers Squibb megadeal that would create world’s biggest drugmaker
By Kelly Gilblom
Read full article →Coverage Timeline
First report: irish-independent · 3 Aug, 09:04|Full coverage: 2 · 2h|Window: 2h
Left-leaningCenterRight-leaning
